A biopharmaceutical company has just received a patent number for their genital herpes vaccine, which puts them one step closer to conducting human trials.
The post After Showing 92% Efficiency in Early Trials, We’re One Step Closer to First Ever Herpes Vaccine appeared first on Good News Network.
from Good News Network https://ift.tt/2LVLeLh
via IFTTT
No comments:
Post a Comment